Focusing the neuroscience and societal implications of cognitive enhancers

Savulich, G., Piercy, T., Brühl, A. B., Fox, C. ORCID: https://orcid.org/0000-0001-9480-5704, Suckling, J., Rowe, J. B., O'Brien, J. T. and Sahakian, B. J. (2017) Focusing the neuroscience and societal implications of cognitive enhancers. Clinical Pharmacology and Therapeutics, 101 (2). 170–172. ISSN 0009-9236

Preview

PDF (Accepted manuscript) - Accepted Version Download (991kB) | Preview

Abstract

Cognitive enhancement can benefit the individual and society, but also has associated risks and ethical concerns. Cognitive-enhancing drugs are used in the treatment of neuropsychiatric disorders. Non-pharmacological strategies are also emerging, which have the potential to improve motivational deficits associated with neuropsychiatric symptoms and should be prioritized for development. The increasing lifestyle use of ‘smart’ and other drugs indicates the desire for healthy people to improve themselves. Safety and ethical implications are discussed.

Item Type:	Article
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Science > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Groups > Mental Health Faculty of Medicine and Health Sciences > Research Centres > Institute for Volunteering Research Faculty of Medicine and Health Sciences > Research Groups > Psychological Sciences (former - to 2018)
Depositing User:	Pure Connector
Date Deposited:	24 Sep 2016 00:54
Last Modified:	20 Apr 2023 00:13
URI:	https://ueaeprints.uea.ac.uk/id/eprint/60269
DOI:	10.1002/cpt.457

Actions (login required)

View Item